Basically, in ASAP, the broad adoption of early cooked or ripened foods, Flour added food materials, is fueling a rise in diabetes cases, which ultimately accelerates demand for GLP-1 receptor agonists
Still, this combination also introduces potential challenges: Potential for low blood sugar: Because GLP-1 medications affect insulin sensitivity and digestion, prolonged fasting can lead to fatigue, dizziness, or hypoglycemia
Standardized protocols for isolation and characterization are urgently needed to make products consistent
A 2022 randomized trial of exenatide did not meet its primary endpoint for reducing heavy drinking days in the overall population, though exploratory analyses suggested potential benefits in participants with obesity
Hims & Hers is hardly the only company that swooped in when name-brand GLP-1s were in short supply